This post was originally published on this site
Mylan announced earnings per share of $1.31 on revenue of $2.97B. Analysts polled by Investing.com anticipated EPS of $1.16 on revenue of $2.99B.
Mylan shares are down 2.47% from the beginning of the year, still down 34.49% from its 52 week high of $23.11 set on February 6. They are under-performing the Nasdaq which is up 32.52% from the start of the year.
Mylan’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Thermo Fisher Scientific had beat expectations on October 21 with third quarter EPS of $5.63 on revenue of $8.52B, compared to forecast for EPS of $4.33 on revenue of $7.65B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
